Report Detail

Pharma & Healthcare Left Ventricular Dysfunction - Pipeline Review, H1 2019

  • RnM2889995
  • |
  • 06 February, 2019
  • |
  • Global
  • |
  • 44 Pages
  • |
  • Global Markets Direct
  • |
  • Pharma & Healthcare

Left Ventricular Dysfunction - Pipeline Review, H1 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2019, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape.

Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Left Ventricular Dysfunction (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Left Ventricular Dysfunction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Left Ventricular Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Phase I stages are 2, 4 and 1 respectively.

Left Ventricular Dysfunction (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Left Ventricular Dysfunction (Cardiovascular).
- The pipeline guide reviews pipeline therapeutics for Left Ventricular Dysfunction (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Left Ventricular Dysfunction (Cardiovascular) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Left Ventricular Dysfunction (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Left Ventricular Dysfunction (Cardiovascular)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Left Ventricular Dysfunction (Cardiovascular).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Left Ventricular Dysfunction (Cardiovascular) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Left Ventricular Dysfunction - Overview

              Left Ventricular Dysfunction - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Products under Development by Companies

                      Left Ventricular Dysfunction - Therapeutics Assessment

                        Assessment by Target

                          Assessment by Mechanism of Action

                            Assessment by Route of Administration

                              Assessment by Molecule Type

                                Left Ventricular Dysfunction - Companies Involved in Therapeutics Development

                                  Bayer AG

                                    Innopharmax Inc

                                      Mesoblast Ltd

                                        Quantum Genomics SA

                                          Takeda Pharmaceutical Co Ltd

                                            Left Ventricular Dysfunction - Drug Profiles

                                              AlloCSC-01 - Drug Profile

                                                Product Description

                                                  Mechanism Of Action

                                                    R&D Progress

                                                      carvedilol CR - Drug Profile

                                                        Product Description

                                                          Mechanism Of Action

                                                            R&D Progress

                                                              firibastat IR - Drug Profile

                                                                Product Description

                                                                  Mechanism Of Action

                                                                    R&D Progress

                                                                      fulacimstat - Drug Profile

                                                                        Product Description

                                                                          Mechanism Of Action

                                                                            R&D Progress

                                                                              MPC-150IM - Drug Profile

                                                                                Product Description

                                                                                  Mechanism Of Action

                                                                                    R&D Progress

                                                                                      NP-202 - Drug Profile

                                                                                        Product Description

                                                                                          Mechanism Of Action

                                                                                            R&D Progress

                                                                                              VBC-01 - Drug Profile

                                                                                                Product Description

                                                                                                  Mechanism Of Action

                                                                                                    R&D Progress

                                                                                                      Left Ventricular Dysfunction - Dormant Projects

                                                                                                        Left Ventricular Dysfunction - Discontinued Products

                                                                                                          Appendix

                                                                                                            Methodology

                                                                                                              Coverage

                                                                                                                Secondary Research

                                                                                                                  Primary Research

                                                                                                                    Expert Panel Validation

                                                                                                                      Contact Us

                                                                                                                        Disclaimer

                                                                                                                        Summary:
                                                                                                                        Get latest Market Research Reports on Left Ventricular Dysfunction. Industry analysis & Market Report on Left Ventricular Dysfunction is a syndicated market report, published as Left Ventricular Dysfunction - Pipeline Review, H1 2019. It is complete Research Study and Industry Analysis of Left Ventricular Dysfunction market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                                        Last updated on

                                                                                                                        REPORT YOU MIGHT BE INTERESTED

                                                                                                                        Purchase this Report

                                                                                                                        $2,000.00
                                                                                                                        $4,000.00
                                                                                                                        $6,000.00
                                                                                                                        1,584.00
                                                                                                                        3,168.00
                                                                                                                        4,752.00
                                                                                                                        1,848.00
                                                                                                                        3,696.00
                                                                                                                        5,544.00
                                                                                                                        302,580.00
                                                                                                                        605,160.00
                                                                                                                        907,740.00
                                                                                                                        166,740.00
                                                                                                                        333,480.00
                                                                                                                        500,220.00
                                                                                                                        Credit card Logo

                                                                                                                        Related Reports


                                                                                                                        Reason to Buy

                                                                                                                        Request for Sample of this report